Which first-line treatment is superior in advanced colorectal cancer: XELOX or pviFOX?

Nat Clin Pract Oncol. 2007 May;4(5):280-1. doi: 10.1038/ncponc0792. Epub 2007 Mar 27.

Author

James Cassidy¹

Affiliation

¹ Cancer Research UK, Department of Medical Oncology, University of Glasgow, Garscube Estate, Glasgow, UK. j.cassidy@beatson.gla.ac.uk

PMID: 17389880
DOI: 10.1038/ncponc0792

No abstract available

Publication types

Comment